Thalassemia Clinical Trial
Official title:
A Case Control Study to Evaluate the Cognitive and Brain Function of β-thalassemia Patients in EMEK MEDICAL CENTER Compare to Healthy Controls.
β-thalassemia syndromes are a group of hereditary disorders characterized by a genetic
deficiency in the synthesis of beta-globin chains.
In recent studies done in β-thalassemia major patients abnormal iron deposition was evident
using MRI in brain structures, cortex, putamen, and caudate nucleus . In most of the cases
the neurological involvement is subclinical. Cognitive functioning was evaluated in beta
thalassemia major, compared with healthy controls, using a neuropsychological battery
including tests of abstract reasoning, attention, executive functions, language,
constructional/visuospatial skills, and memory. Patients with beta thalassemia major, in
particular those showing signs of hemosiderosis, had significantly impaired function in all
neuropsychological tests. There was no relationship between cognitive performances and signs
of deferoxamine toxicity, deferoxamine dosage, and levels of hemoglobin and ferritin.
Event-related potentials (ERPs) are one of the most informative and dynamic methods of
monitoring the information stream in the living brain. ERPs are linked in time with a
physical or mental event, and are typically extracted from the scalp-recorded
electroencephalogram (EEG) by means of signal averaging.
ERPs have been used in the assessment of cognitive function in several disorders, including
anemia and iron deficiency anemia. However, literature regarding cognitive function and ERP
activity in thalassemia patients is extremely limited, especially in adults.
The purpose of this study is to evaluate the cognitive and brain function in a group of 60
thalassemia patients and compare the results to healthy controls.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04398628 -
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
|
||
| Completed |
NCT04614779 -
Long-term Clinical Study of CN128 in Thalassemia Patients
|
Phase 2 | |
| Completed |
NCT01158794 -
Genes Influencing Iron Overload State
|
||
| Recruiting |
NCT02995707 -
The Effective and Safety of Thalidomide in NTDT
|
Phase 2 | |
| Terminated |
NCT01319851 -
Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation
|
N/A | |
| Completed |
NCT00901199 -
Combined Chelation Therapy in Patients With Transfusion Dependent Thalassemia and Iron Overload
|
Phase 2 | |
| Terminated |
NCT00034528 -
Stem Cell Transplantation After Reduced-Dose Chemotherapy for Patients With Sickle Cell Disease or Thalassemia
|
Phase 2 | |
| Active, not recruiting |
NCT03655678 -
A Safety and Efficacy Study Evaluating CTX001 in Subjects With Transfusion-Dependent β-Thalassemia
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05508932 -
Atrial Fibrillation in Beta-Thalassemia
|
||
| Completed |
NCT03609827 -
Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients
|
||
| Completed |
NCT03117192 -
Zinc Supplementation on Cellular Immunity in Thalassemia Major
|
Phase 4 | |
| Completed |
NCT03095326 -
Pneumococcal Vaccination for Splenectomised Thalassemia Major Patients in Indonesia
|
Phase 4 | |
| Completed |
NCT01443312 -
Demographic, Clinical, Laboratory and Genetical Characteristics of Patients With Beta Thalassemia Intermedia
|
||
| Completed |
NCT00744692 -
Reduced Intensity Conditioning for Umbilical Cord Blood Transplant in Pediatric Patients With Non-Malignant Disorders
|
Phase 1 | |
| Completed |
NCT00235391 -
Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload
|
Phase 3 | |
| Not yet recruiting |
NCT06058260 -
Assessment of Cognitive Function and Quality of Life in Thalassemic Children at Sohag University Hospital
|
||
| Completed |
NCT05529550 -
Assessment of Nutritional Status and Role of Insulin-like Growth Factor-1 in Children
|
||
| Completed |
NCT04582110 -
The Role of OCTA in Patients Affected by Beta Thalassemia
|
||
| Recruiting |
NCT06213402 -
RADeep Multicenter European Epidemiological Platform for Patients Diagnosed With Rare Anemia Disorders (RADs)
|
||
| Recruiting |
NCT01758042 -
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders
|
N/A |